Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Joseph Melenhorst

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cancer Immunology Research|August 2, 2022
Adaptable Leukemia Cells Resisting CAR T-cell Attack via B-cell ActivationZiran Zhao, Jan Joseph Melenhorst
International Journal of Molecular Sciences|March 10, 2022
STAT3 Role in T-Cell Memory FormationYaroslav Kaminskiy, Jan Joseph Melenhorst
Cytotherapy|November 12, 2010
Tumor vaccines and beyondJan Joseph Melenhorst, Austin John Barrett
Cancer Immunology Research|April 2, 2024
Allogeneic CAR T Cells: Complex Cellular Therapy Designs Test the Limits of Our Preclinical ModelsPaolo F Caimi, Jan Joseph Melenhorst
Cell Research|April 4, 2023
Positively charged patches: tonic for CAR fitnessMeraj H Khan, Jan Joseph Melenhorst
Science Translational Medicine|June 22, 2022
B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?Gregory M Chen, Jan Joseph Melenhorst, Kai Tan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2025
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell LymphomaArun Kumar Arunachalam, Cassandra K Gilmour, Jan Joseph Melenhorst
Seminars in Hematology|April 20, 2023
Challenges and opportunities of CAR T-cell therapies for CLLZiran Zhao, Céline Grégoire, Beatriz Oliveira, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.
Biomarkers in Medicine|April 27, 2018
Biomarkers in chimeric antigen receptor T-cell therapyWeimin Kong, Simon F Lacey, Jan Joseph Melenhorst, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancer Immunology Research|August 2, 2022
Adaptable Leukemia Cells Resisting CAR T-cell Attack via B-cell ActivationZiran Zhao, Jan Joseph Melenhorst
International Journal of Molecular Sciences|March 10, 2022
STAT3 Role in T-Cell Memory FormationYaroslav Kaminskiy, Jan Joseph Melenhorst
Cytotherapy|November 12, 2010
Tumor vaccines and beyondJan Joseph Melenhorst, Austin John Barrett
Cancer Immunology Research|April 2, 2024
Allogeneic CAR T Cells: Complex Cellular Therapy Designs Test the Limits of Our Preclinical ModelsPaolo F Caimi, Jan Joseph Melenhorst
Cell Research|April 4, 2023
Positively charged patches: tonic for CAR fitnessMeraj H Khan, Jan Joseph Melenhorst
Science Translational Medicine|June 22, 2022
B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?Gregory M Chen, Jan Joseph Melenhorst, Kai Tan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2025
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell LymphomaArun Kumar Arunachalam, Cassandra K Gilmour, Jan Joseph Melenhorst
Seminars in Hematology|April 20, 2023
Challenges and opportunities of CAR T-cell therapies for CLLZiran Zhao, Céline Grégoire, Beatriz Oliveira, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.
Biomarkers in Medicine|April 27, 2018
Biomarkers in chimeric antigen receptor T-cell therapyWeimin Kong, Simon F Lacey, Jan Joseph Melenhorst, et al.
Pageof 4